Original Research

Published on 21 Apr 2021

TP53-Activated lncRNA GHRLOS Regulates Cell Proliferation, Invasion, and Apoptosis of Non-Small Cell Lung Cancer by Modulating the miR-346/APC Axis

in Pharmacology of Anti-Cancer Drugs

Ke Ren
Jinghui Sun
Lingling Liu
Yuping Yang
Honghui Li
Zhichao Wang
Jingzhu Deng
Min Hou
Jia Qiu
Wei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.676202

3,932 views
10 citations

Original Research

Published on 20 Apr 2021

Astragaloside IV and Saponins of Rhizoma Polygonati Cure Cyclophosphamide-Induced Myelosuppression in Lung Adenocarcinoma via Down-Regulating miR-142-3p

in Pharmacology of Anti-Cancer Drugs

Xian Gu
Ling-yu Zhu
Zhen-ye Xu
Ke-ping Shen

Frontiers in Oncology

doi 10.3389/fonc.2021.630921

3,654 views
13 citations

Original Research

Published on 19 Apr 2021

Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity

in Pharmacology of Anti-Cancer Drugs

Hongyan Liu
Shishuo Sun
Gang Wang
Mengmeng Lu
Xiaokang Zhang
Xiaohuan Wei
Xiaoge Gao
Chao Huang
Zhen Li
Junnian Zheng

Frontiers in Oncology

doi 10.3389/fonc.2021.663517

5,204 views
13 citations

Original Research

Published on 16 Apr 2021

LCT-3d Induces Oxidative Stress-Mediated Apoptosis by Upregulating Death Receptor 5 in Gastric Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Menglin Wang
Xinxin Wu
Lu Yu
Zi-yun Hu
Xiaobo Li
Xia Meng
Chun-tao Lv
Gi-Young Kim
Yung Hyun Choi
Zhengya Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.658608

2,552 views
5 citations

Systematic Review

Published on 16 Apr 2021

Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Shixue Chen
Zhibo Zhang
Xuan Zheng
Haitao Tao
Sujie Zhang
Junxun Ma
Zhefeng Liu
Jinliang Wang
Yuanyu Qian
Pengfei Cui

Frontiers in Oncology

doi 10.3389/fonc.2021.562315

14,367 views
76 citations

Original Research

Published on 13 Apr 2021

Fucoidan Inhibits the Progression of Hepatocellular Carcinoma via Causing lncRNA LINC00261 Overexpression

in Pharmacology of Anti-Cancer Drugs

Danhui Ma
Jiayi Wei
Sinuo Chen
Heming Wang
Liuxin Ning
Shi-Hua Luo
Chieh-Lun Liu
Guangqi Song
Qunyan Yao

Frontiers in Oncology

doi 10.3389/fonc.2021.653902

5,728 views
23 citations

Review

Published on 12 Apr 2021

Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways

in Pharmacology of Anti-Cancer Drugs

Haijun Wang
Ke Zhang
Jia Liu
Jie Yang
Yidan Tian
Chen Yang
Yushan Li
Minglong Shao
Wei Su
Na Song

Frontiers in Oncology

doi 10.3389/fonc.2021.660712

10,348 views
49 citations

Original Research

Published on 06 Apr 2021

CDK7 Inhibitor THZ1 Induces the Cell Apoptosis of B-Cell Acute Lymphocytic Leukemia by Perturbing Cellular Metabolism

in Pharmacology of Anti-Cancer Drugs

Tuersunayi Abudureheman
Jing Xia
Ming-Hao Li
Hang Zhou
Wei-Wei Zheng
Neng Zhou
Rong-Yi Shi
Jian-Min Zhu
Li-Ting Yang
Li Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.663360

5,744 views
16 citations

Case Report

Published on 01 Apr 2021

Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases

in Pharmacology of Anti-Cancer Drugs

Margaux Geier
Hélène Babey
Lucie Monceau-Baroux
Gilles Quéré
Renaud Descourt
Divi Cornec
Gilles Robinet

Frontiers in Oncology

doi 10.3389/fonc.2021.644282

2,305 views
3 citations

Original Research

Published on 01 Apr 2021

Capilliposide C from Lysimachia capillipes Restores Radiosensitivity in Ionizing Radiation-Resistant Lung Cancer Cells Through Regulation of ERRFI1/EGFR/STAT3 Signaling Pathway

in Pharmacology of Anti-Cancer Drugs

Kan Wu
Xueqin Chen
Jianguo Feng
Shirong Zhang
Yasi Xu
Jingjing Zhang
Qiong Wu
Mingliang You
Bing Xia
Shenglin Ma

Frontiers in Oncology

doi 10.3389/fonc.2021.644117

3,823 views
4 citations

Original Research

Published on 01 Apr 2021

Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer

in Pharmacology of Anti-Cancer Drugs

Jiaming Wan
Cheng Guo
Hongpeng Fang
Zhongye Xu
Yongwei Hu
Yun Luo

Frontiers in Oncology

doi 10.3389/fonc.2021.647236

6,154 views
41 citations

Original Research

Published on 30 Mar 2021

Transcriptome Analysis of Ivosidenib-Mediated Inhibitory Functions on Non-Small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Juan Wu
Ru Chen
Huiqing Shen
Ting Yan
Yu Qian
Yaping Zhang
Zhuoya Huang
Pengzhou Kong
Min Pang
Xinri Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.626605

4,424 views
2 citations

Original Research

Published on 29 Mar 2021

MiR-450a-5p Inhibits Gastric Cancer Cell Proliferation, Migration, and Invasion and Promotes Apoptosis via Targeting CREB1 and Inhibiting AKT/GSK-3β Signaling Pathway

in Pharmacology of Anti-Cancer Drugs

Ya-Jun Zhao
Jun Zhang
Yong-Cang Wang
Liang Wang
Xin-Yang He

Frontiers in Oncology

doi 10.3389/fonc.2021.633366

2,805 views
13 citations

Original Research

Published on 26 Mar 2021

Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements via Multiple Signaling Pathways

in Pharmacology of Anti-Cancer Drugs

Mei Qu
Yu Duan
Min Zhao
Zhanju Wang
Mengjie Zhao
Yao Zhao
Haihua Wang
Yu Ke
Ying Liu
Hong-Min Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.659720

4,240 views
11 citations

Original Research

Published on 26 Mar 2021

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications

in Pharmacology of Anti-Cancer Drugs

Bashir Lawal
Ching-Yu Lee
Ntlotlang Mokgautsi
Maryam Rachmawati Sumitra
Harshita Khedkar
Alexander T.H. Wu
Hsu-Shan Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.656738

6,916 views
46 citations

Review

Published on 26 Mar 2021

Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Haoming Xia
Ziyue Huang
Shuqiang Liu
Xudong Zhao
Risheng He
Zhongrui Wang
Wenguang Shi
Wangming Chen
Zhizhou Li
Liang Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.653846

4,799 views
3 citations

Navigation group

Articles

TP53-Activated lncRNA GHRLOS Regulates Cell Proliferation, Invasion, and Apoptosis of Non-Small Cell Lung Cancer by Modulating the miR-346/APC Axis

Astragaloside IV and Saponins of Rhizoma Polygonati Cure Cyclophosphamide-Induced Myelosuppression in Lung Adenocarcinoma via Down-Regulating miR-142-3p

Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity

LCT-3d Induces Oxidative Stress-Mediated Apoptosis by Upregulating Death Receptor 5 in Gastric Cancer Cells

Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis

Fucoidan Inhibits the Progression of Hepatocellular Carcinoma via Causing lncRNA LINC00261 Overexpression

Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways

CDK7 Inhibitor THZ1 Induces the Cell Apoptosis of B-Cell Acute Lymphocytic Leukemia by Perturbing Cellular Metabolism

Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases

Capilliposide C from Lysimachia capillipes Restores Radiosensitivity in Ionizing Radiation-Resistant Lung Cancer Cells Through Regulation of ERRFI1/EGFR/STAT3 Signaling Pathway

Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer

Transcriptome Analysis of Ivosidenib-Mediated Inhibitory Functions on Non-Small Cell Lung Cancer

MiR-450a-5p Inhibits Gastric Cancer Cell Proliferation, Migration, and Invasion and Promotes Apoptosis via Targeting CREB1 and Inhibiting AKT/GSK-3β Signaling Pathway

Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements via Multiple Signaling Pathways

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications

Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma